X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Fulford India with Dishman Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FULFORD INDIA vs DISHMAN PHARMA - Comparison Results

FULFORD INDIA    Change

Fulford (India) Limited is an Indian affiliate of Schering-Plough Corporation, USA. The company has presence in oncology, virology and cardiovascular segments. In FY06 the topline of the company grew by 15.5% to Rs. 1519 m from Rs. 1279 m in FY05. PA... More

DISHMAN PHARMA 
   Change

Dishman Pharmaceuticals is involved in the manufacture of APIs (active pharmaceutical ingredients), intermediates, quaternary compounds and fine chemicals. Besides this, the company is a significant player in the CRAMS (Contract Research and Manufact... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    FULFORD INDIA DISHMAN PHARMA FULFORD INDIA/
DISHMAN PHARMA
 
P/E (TTM) x 398.8 25.1 1,589.4% View Chart
P/BV x 6.2 3.3 185.7% View Chart
Dividend Yield % 0.1 0.7 12.7%  

Financials

 FULFORD INDIA   DISHMAN PHARMA
EQUITY SHARE DATA
    FULFORD INDIA
Mar-14
DISHMAN PHARMA
Mar-16
FULFORD INDIA/
DISHMAN PHARMA
5-Yr Chart
Click to enlarge
High Rs942374 251.6%   
Low Rs450129 349.1%   
Sales per share (Unadj.) Rs691.4197.8 349.5%  
Earnings per share (Unadj.) Rs11.521.2 54.0%  
Cash flow per share (Unadj.) Rs15.434.7 44.2%  
Dividends per share (Unadj.) Rs2.002.00 100.0%  
Dividend yield (eoy) %0.30.8 36.2%  
Book value per share (Unadj.) Rs380.0179.9 211.2%  
Shares outstanding (eoy) m3.9080.69 4.8%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.01.3 79.1%   
Avg P/E ratio x60.711.9 511.7%  
P/CF ratio (eoy) x45.37.2 625.2%  
Price / Book Value ratio x1.81.4 130.9%  
Dividend payout %17.49.4 185.0%   
Avg Mkt Cap Rs m2,71420,306 13.4%   
No. of employees `0000.40.8 53.6%   
Total wages/salary Rs m5055,355 9.4%   
Avg. sales/employee Rs Th6,073.019,252.7 31.5%   
Avg. wages/employee Rs Th1,137.46,459.5 17.6%   
Avg. net profit/employee Rs Th100.72,064.1 4.9%   
INCOME DATA
Net Sales Rs m2,69615,961 16.9%  
Other income Rs m125265 47.2%   
Total revenues Rs m2,82216,226 17.4%   
Gross profit Rs m-464,103 -1.1%  
Depreciation Rs m151,091 1.4%   
Interest Rs m10944 1.0%   
Profit before tax Rs m542,334 2.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m01 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m10624 1.5%   
Profit after tax Rs m451,711 2.6%  
Gross profit margin %-1.725.7 -6.7%  
Effective tax rate %17.726.7 66.2%   
Net profit margin %1.710.7 15.5%  
BALANCE SHEET DATA
Current assets Rs m1,73811,018 15.8%   
Current liabilities Rs m5459,517 5.7%   
Net working cap to sales %44.39.4 470.7%  
Current ratio x3.21.2 275.7%  
Inventory Days Days48110 43.9%  
Debtors Days Days435 12.4%  
Net fixed assets Rs m1216,304 0.1%   
Share capital Rs m39161 24.2%   
"Free" reserves Rs m1,44312,907 11.2%   
Net worth Rs m1,48214,516 10.2%   
Long term debt Rs m04,189 0.0%   
Total assets Rs m2,07729,805 7.0%  
Interest coverage x6.73.5 193.5%   
Debt to equity ratio x00.3 0.0%  
Sales to assets ratio x1.30.5 242.5%   
Return on assets %2.68.9 29.3%  
Return on equity %3.011.8 25.6%  
Return on capital %4.317.5 24.6%  
Exports to sales %024.8 0.0%   
Imports to sales %24.53.7 654.4%   
Exports (fob) Rs mNA3,956 0.0%   
Imports (cif) Rs m659596 110.6%   
Fx inflow Rs m174,952 0.3%   
Fx outflow Rs m673697 96.6%   
Net fx Rs m-6564,255 -15.4%   
CASH FLOW
From Operations Rs m902,786 3.2%  
From Investments Rs m105-1,529 -6.8%  
From Financial Activity Rs m-14-941 1.5%  
Net Cashflow Rs m181316 57.0%  

Share Holding

Indian Promoters % 0.0 61.4 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 3.8 3.7 102.7%  
FIIs % 0.1 12.7 0.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 21.2 22.1 95.9%  
Shareholders   4,783 46,261 10.3%  
Pledged promoter(s) holding % 0.0 35.8 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare FULFORD INDIA With:   SUVEN LIFE  SHASUN PHARMA  PFIZER  FDC LTD.  ORCHID PHARMA LTD  

Compare FULFORD INDIA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens Higher; Realty & Pharma Stocks Lead(09:30 am)

Asian stock indices are trading mixed today. The Shanghai Composite is lower by 0.29% while the Hang Seng is even. The Nikkei 225 is trading higher by 0.46%.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

Aug 17, 2017

A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

FULFORD INDIA SHARE PRICE


Jul 30, 2015 (Close)

TRACK FULFORD INDIA

  • Track your investment in FULFORD INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

FULFORD INDIA 5-YR ANALYSIS

COMPARE FULFORD INDIA WITH

MARKET STATS